The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor samples from women with family history strongly suggestive of hereditary breast/ovarian cancer. This evidence concerns the gene BRCA1 and Hereditary breast and ovarian cancer syndrome.